Patents by Inventor Masahiro Tamaru

Masahiro Tamaru has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11916183
    Abstract: The power storage device includes power storage units arranged with a conductive plate interposed therebetween in the vertical direction, each of the power storage units includes an electrode stack including bipolar electrodes stacked with a separator interposed therebetween, and a sealing member provided around the electrode stack so as to seal a housing space formed between adjacent electrodes of the electrode stack. At least one of the power storage units is provided with an overhang member on an outer peripheral surface of the sealing member. The overhang member includes an inclined portion that extends from the outer peripheral surface of the sealing member toward the outside of the power storage unit and inclines downward as it leaves away from the outer peripheral surface of the sealing member, and a top portion formed at a lower end of the inclined portion.
    Type: Grant
    Filed: December 24, 2019
    Date of Patent: February 27, 2024
    Assignees: TOYOTA JIDOSHA KABUSHIKI KAISHA, KABUSHIKI KAISHA TOYOTA JIDOSHOKKI
    Inventors: Daiki Terashima, Satoshi Morioka, Takuro Kikuchi, Motoyoshi Okumura, Kojiro Tamaru, Hiromi Ueda, Satoshi Hamaoka, Masahiro Yamada
  • Publication number: 20220380362
    Abstract: The present invention relates to a pyrimidine compound or a pharmaceutically acceptable salt thereof represented by the following formula [I] wherein each symbol is as defined in the specification and a method of therapeutically or prophylactically treating an undesirable cell proliferation, comprising administering such a compound. The compound of the present invention has superior activity in suppressing undesirable cell proliferation, particularly, an antitumor activity, and is useful as an antitumor agent for the prophylaxis or treatment of cancer, rheumatism, and the like. In addition, the compound of the present invention can be a more effective antitumor agent when used in combination with other antitumor agents such as an alkylating agent or metabolism antagonist.
    Type: Application
    Filed: December 8, 2021
    Publication date: December 1, 2022
    Applicant: Japan Tobacco Inc.
    Inventors: Hisashi KAWASAKI, Hiroyuki ABE, Kazuhide HAYAKAWA, Tetsuya IIDA, Shinichi KIKUCHI, Takayuki YAMAGUCHI, Toyomichi NANAYAMA, Hironori KURACHI, Masahiro TAMARU, Yoshikazu HORI, Mitsuru TAKAHASHI, Takayuki YOSHIDA, Toshiyuki SAKAI
  • Publication number: 20200109139
    Abstract: The present invention relates to a pyrimidine compound or a pharmaceutically acceptable salt thereof represented by the following formula [I] wherein each symbol is as defined in the specification and a method of therapeutically or prophylactically treating an undesirable cell proliferation, comprising administering such a compound. The compound of the present invention has superior activity in suppressing undesirable cell proliferation, particularly, an antitumor activity, and is useful as an antitumor agent for the prophylaxis or treatment of cancer, rheumatism, and the like. In addition, the compound of the present invention can be a more effective antitumor agent when used in combination with other antitumor agents such as an alkylating agent or metabolism antagonist.
    Type: Application
    Filed: May 20, 2019
    Publication date: April 9, 2020
    Applicant: Japan Tobacco Inc.
    Inventors: Hisashi KAWASAKI, Hiroyuki ABE, Kazuhide HAYAKAWA, Tetsuya IIDA, Shinichi KIKUCHI, Takayuki YAMAGUCHI, Toyomichi NANAYAMA, Hironori KURACHI, Masahiro TAMARU, Yoshikazu HORI, Mitsuru TAKAHASHI, Takayuki YOSHIDA, Toshiyuki SAKAI
  • Publication number: 20180273531
    Abstract: The present invention relates to a pyrimidine compound or a pharmaceutically acceptable salt thereof represented by the following formula [I] wherein each symbol is as defined in the specification and a method of therapeutically or prophylactically treating an undesirable cell proliferation, comprising administering such a compound. The compound of the present invention has superior activity in suppressing undesirable cell proliferation, particularly, an antitumor activity, and is useful as an antitumor agent for the prophylaxis or treatment of cancer, rheumatism, and the like. In addition, the compound of the present invention can be a more effective antitumor agent when used in combination with other antitumor agents such as an alkylating agent or metabolism antagonist.
    Type: Application
    Filed: October 27, 2017
    Publication date: September 27, 2018
    Applicant: Japan Tobacco Inc.
    Inventors: Hisashi KAWASAKI, Hiroyuki ABE, Kazuhide HAYAKAWA, Tetsuya IIDA, Shinichi KIKUCHI, Takayuki YAMAGUCHI, Toyomichi NANAYAMA, Hironori KURACHI, Masahiro TAMARU, Yoshikazu HORI, Mitsuru TAKAHASHI, Takayuki YOSHIDA, Toshiyuki SAKAI
  • Publication number: 20170029418
    Abstract: The present invention relates to a pyrimidine compound or a pharmaceutically acceptable salt thereof represented by the following formula [I] wherein each symbol is as defined in the specification and a method of therapeutically or prophylactically treating an undesirable cell proliferation, comprising administering such a compound. The compound of the present invention has superior activity in suppressing undesirable cell proliferation, particularly, an antitumor activity, and is useful as an antitumor agent for the prophylaxis or treatment of cancer, rheumatism, and the like. In addition, the compound of the present invention can be a more effective antitumor agent when used in combination with other antitumor agents such as an alkylating agent or metabolism antagonist.
    Type: Application
    Filed: February 24, 2016
    Publication date: February 2, 2017
    Applicant: Japan Tobacco Inc.
    Inventors: Hisashi KAWASAKI, Hiroyuki ABE, Kazuhide HAYAKAWA, Tetsuya IIDA, Shinichi KIKUCHI, Takayuki YAMAGUCHI, Toyomichi NANAYAMA, Hironori KURACHI, Masahiro TAMARU, Yoshikazu HORI, Mitsuru TAKAHASHI, Takayuki YOSHIDA, Toshiyuki SAKAI
  • Publication number: 20150183812
    Abstract: The present invention relates to a pyrimidine compound or a pharmaceutically acceptable salt thereof represented by the following formula [I] wherein each symbol is as defined in the specification and a method of therapeutically or prophylactically treating an undesirable cell proliferation, comprising administering such a compound. The compound of the present invention has superior activity in suppressing undesirable cell proliferation, particularly, an antitumor activity, and is useful as an antitumor agent for the prophylaxis or treatment of cancer, rheumatism, and the like. In addition, the compound of the present invention can be a more effective antitumor agent when used in combination with other antitumor agents such as an alkylating agent or metabolism antagonist.
    Type: Application
    Filed: August 7, 2014
    Publication date: July 2, 2015
    Inventors: Hisashi KAWASAKI, Hiroyuki ABE, Kazuhide HAYAKAWA, Tetsuya IIDA, Shinichi KIKUCHI, Takayuki YAMAGUCHI, Toyomichi NANAYAMA, Hironori KURACHI, Masahiro TAMARU, Yoshikazu HORI, Mitsuru TAKAHASHI, Takayuki YOSHIDA, Toshiyuki SAKAI
  • Patent number: 8977798
    Abstract: The present invention provides an electronic system mounted on an aircraft which can effectively reduce electronic devices and wires by integration of control systems. Specifically, a fuselage (80) of an aircraft (100) is divided into a nose part (80a), a center part (80b), and an aft part (80c), and two IMAs (integrated modular avionics units) (50a to 50c) are provided in each of these parts. The IMA units (50a to 50c) are interconnected via an integrated data bus (53) to construct an integrated electronic system mounted on the aircraft. The system is suitably used for integrating utility systems except for avionics systems, among a plurality of control systems mounted on the aircraft, and is also applicable to integration of the avionics systems.
    Type: Grant
    Filed: December 14, 2010
    Date of Patent: March 10, 2015
    Assignee: Kawasaki Jukogyo Kabushiki Kaisha
    Inventors: Yoichi Mitani, Masahiro Tamaru, Reiichi Ikarashi, Taisei Isobe
  • Patent number: 8835443
    Abstract: The present invention relates to a pyrimidine compound or a pharmaceutically acceptable salt thereof represented by the following formula [I] wherein each symbol is as defined in the specification and a method of therapeutically or prophylactically treating an undesirable cell proliferation, comprising administering such a compound. The compound of the present invention has superior activity in suppressing undesirable cell proliferation, particularly, an antitumor activity, and is useful as an antitumor agent for the prophylaxis or treatment of cancer, rheumatism, and the like. In addition, the compound of the present invention can be a more effective antitumor agent when used in combination with other antitumor agents such as an alkylating agent or metabolism antagonist.
    Type: Grant
    Filed: November 25, 2009
    Date of Patent: September 16, 2014
    Assignee: Japan Tobacco Inc.
    Inventors: Hisashi Kawasaki, Hiroyuki Abe, Kazuhide Hayakawa, Tetsuya Iida, Shinichi Kikuchi, Takayuki Yamaguchi, Toyomichi Nanayama, Hironori Kurachi, Masahiro Tamaru, Yoshikazu Hori, Mitsuru Takahashi, Takayuki Yoshida, Toshiyuki Sakai
  • Publication number: 20120297108
    Abstract: The present invention provides an electronic system mounted on an aircraft which can effectively reduce electronic devices and wires by integration of control systems. Specifically, a fuselage (80) of an aircraft (100) is divided into a nose part (80a), a center part (80b), and an aft part (80c), and two IMAs (integrated modular avionics units) (50a to 50c) are provided in each of these parts. The IMA units (50a to 50c) are interconnected via an integrated data bus (53) to construct an integrated electronic system mounted on the aircraft. The system is suitably used for integrating utility systems except for avionics systems, among a plurality of control systems mounted on the aircraft, and is also applicable to integration of the avionics systems.
    Type: Application
    Filed: December 14, 2010
    Publication date: November 22, 2012
    Applicant: KAWASAKI JUKOGYO KABUSHIKI KAISHA
    Inventors: Yoichi Mitani, Masahiro Tamaru, Reiichi Ikarashi, Taisei Isobe
  • Publication number: 20100240613
    Abstract: The present invention relates to a pyrimidine compound or a pharmaceutically acceptable salt thereof represented by the following formula [I] wherein each symbol is as defined in the specification and a method of therapeutically or prophylactically treating an undesirable cell proliferation, comprising administering such a compound. The compound of the present invention has superior activity in suppressing undesirable cell proliferation, particularly, an antitumor activity, and is useful as an antitumor agent for the prophylaxis or treatment of cancer, rheumatism, and the like. In addition, the compound of the present invention can be a more effective antitumor agent when used in combination with other antitumor agents such as an alkylating agent or metabolism antagonist.
    Type: Application
    Filed: November 25, 2009
    Publication date: September 23, 2010
    Applicant: Japan Tobacco Inc.
    Inventors: Hisashi Kawasaki, Hiroyuki Abe, Kazuhide Hayakawa, Tetsuya Iida, Shinichi Kikuchi, Takayuki Yamaguchi, Toyomichi Nanayama, Hironori Kurachi, Masahiro Tamaru, Yoshikazu Hori, Mitsuru Takahashi, Takayuki Yoshida, Toshiyuki Sakai
  • Publication number: 20080312228
    Abstract: The present invention relates to a pyrimidine compound or a pharmaceutically acceptable salt thereof represented by the following formula [I] wherein each symbol is as defined in the specification and a method of therapeutically or prophylactically treating an undesirable cell proliferation, comprising administering such a compound. The compound of the present invention has superior activity in suppressing undesirable cell proliferation, particularly, an antitumor activity, and is useful as an antitumor agent for the prophylaxis or treatment of cancer, rheumatism, and the like. In addition, the compound of the present invention can be a more effective antitumor agent when used in combination with other antitumor agents such as an alkylating agent or metabolism antagonist.
    Type: Application
    Filed: March 21, 2008
    Publication date: December 18, 2008
    Applicant: Japan Tobacco Inc.
    Inventors: Hisashi Kawasaki, Hiroyuki Abe, Kazuhide Hayakawa, Tetsuya Iida, Shinichi Kikuchi, Takayuki Yamaguchi, Toyomichi Nanayama, Hironori Kurachi, Masahiro Tamaru, Yoshikazu Hori, Mitsuru Takahashi, Takayuki Yoshida, Toshiyuki Sakai
  • Patent number: 7378423
    Abstract: The present invention relates to a pyrimidine compound or a pharmaceutically acceptable salt thereof represented by the following formula [I] wherein each symbol is as defined in the specification and a method of therapeutically or prophylactically treating an undesirable cell proliferation, comprising administering such a compound. The compound of the present invention has superior activity in suppressing undesirable cell proliferation, particularly, an antitumor activity, and is useful as an antitumor agent for the prophylaxis or treatment of cancer, rheumatism, and the like. In addition, the compound of the present invention can be a more effective antitumor agent when used in combination with other antitumor agents such as an alkylating agent or metabolism antagonist.
    Type: Grant
    Filed: June 10, 2005
    Date of Patent: May 27, 2008
    Assignee: Japan Tobacco Inc.
    Inventors: Hisashi Kawasaki, Hiroyuki Abe, Kazuhide Hayakawa, Tetsuya Iida, Shinichi Kikuchi, Takayuki Yamaguchi, Toyomichi Nanayama, Hironori Kurachi, Masahiro Tamaru, Yoshikazu Hori, Mitsuru Takahashi, Takayuki Yoshida, Toshiyuki Sakai
  • Publication number: 20060014768
    Abstract: The present invention relates to a pyrimidine compound or a pharmaceutically acceptable salt thereof represented by the following formula [I] wherein each symbol is as defined in the specification and a method of therapeutically or prophylactically treating an undesirable cell proliferation, comprising administering such a compound. The compound of the present invention has superior activity in suppressing undesirable cell proliferation, particularly, an antitumor activity, and is useful as an antitumor agent for the prophylaxis or treatment of cancer, rheumatism, and the like. In addition, the compound of the present invention can be a more effective antitumor agent when used in combination with other antitumor agents such as an alkylating agent or metabolism antagonist.
    Type: Application
    Filed: June 10, 2005
    Publication date: January 19, 2006
    Applicant: Japan Tobacco Inc.
    Inventors: Hisashi Kawasaki, Hiroyuki Abe, Kazuhide Hayakawa, Tetsuya Iida, Shinichi Kikuchi, Takayuki Yamaguchi, Toyomichi Nanayama, Hironori Kurachi, Masahiro Tamaru, Yoshikazu Hori, Mitsuru Takahashi, Takayuki Yoshida, Toshiyuki Sakai